Nuance Communications’ latest survey is highlighting the differences between boomers and millennials when it comes to how they interact with their health care experience.
With Naurex, Allergan potentially expands its development of mental health treatments, as the acquired company’s focus is on developing therapies for brain and nervous system disorders like depression.
The Pharmacy Quality Alliance on Monday introduced a new performance measure initiative that examines how patient socioeconomic and demographic characteristics affect performance measures.
The combination of resources is aimed at providing diabetes patients better tools for self-management and giving healthcare providers more tools to support patients, according to the companies.
Alvogen on Wednesday announced that it will acquire a portfolio of four pharmaceutical products in the United States from Pfizer.
Vaccine exemption levels for kindergarteners are low for most states and infant vaccination rates are high nationwide, according to the week’s Morbidity and Mortality Weekly Report from the Centers for Disease Control and Prevention.
The Food and Drug Administration has a new diabetes treatment developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co.
Vermont on Friday became the last state in the nation to legalize electronic prescriptions for controlled substances — a measure that many states have adopted as a way to combat the abuse of controlled substances and prevent individuals from resorting to fraudulent paper prescriptions.
Amgen announced Friday that the Food and Drug Administration had approved its new cholesterol treatment Repatha (evolocumab) injection.